Hadi Mostafaei
Tabriz University of Medical Sciences
Internal medicineUrologyOncologyAdverse effectHazard ratioCystectomyRenal cell carcinomaCarcinomaDiseaseProstatectomyProstate cancerBladder cancerIn patientUrothelial carcinomaConfidence intervalProportional hazards modelMedicineBiomarker (medicine)Meta-analysis
93Publications
9H-index
148Citations
Publications 107
Newest
#1Hanieh Salehi-Pourmehr (Tabriz University of Medical Sciences)H-Index: 8
#2Ozra Nouri (Tabriz University of Medical Sciences)
Last. Hashim HashimH-Index: 23
view all 14 authors...
This review aims to investigate the effect of stem cell (SC) therapy on the management of neurogenic bladder (NGB) in four neurological diseases, including spinal cord injury (SCI), Parkinson’s disease (PD), multiple sclerosis (MS), and stroke, in the clinical setting. An electronic database search was conducted in the Cochrane Library, EMBASE, Proquest, null null null null null null null null null null null null null null null null Clinicaltrial.gov null null null null null null null null null ...
Source
#1Takafumi Yanagisawa (Medical University of Vienna)
#2Keiichiro Mori (Medical University of Vienna)H-Index: 10
Last. Shahrokh F. ShariatH-Index: 136
view all 16 authors...
Pembrolizumab is the standard for the first and second lines in treating metastatic urothelial carcinoma (UC). This systematic review and meta-analysis aimed to assess the value of pretreatment clinical characteristics and hematologic biomarkers for prognosticating response to pembrolizumab in patients with metastatic UC. PUBMED®, Web of Science™, and Scopus® databases were searched for articles published before May 2021 according to the PRISMA (Preferred Reporting Items for Systematic Review an...
Source
#1Ekaterina Laukhtina (Medical University of Vienna)H-Index: 8
#2Sung Ryul Shim (KU: Korea University)H-Index: 1
Last. Benjamin Pradere (Medical University of Vienna)H-Index: 16
view all 22 authors...
Abstract null null Context null During the past decade, several urinary biomarker tests (UBTs) for bladder cancer have been developed and made commercially available. However, none of these is recommended by international guidelines so far. null null null Objective null To assess the diagnostic estimates of novel commercially available UBTs for diagnosis and surveillance of non–muscle-invasive bladder cancer (NMIBC) using diagnostic test accuracy (DTA) and network meta-analysis (NMA). null null ...
Source
#1Ekaterina Laukhtina (Medical University of Vienna)H-Index: 8
#2Victor M. Schuettfort (UHH: University of Hamburg)H-Index: 5
Last. Shahrokh F. ShariatH-Index: 136
view all 16 authors...
Introduction null This study aimed to determine the prognostic value of a panel of SIR-biomarkers, relative to standard clinicopathological variables, to improve mRCC patient selection for cytoreductive nephrectomy (CN). null Material and methods null A panel of preoperative SIR-biomarkers, including the albumin-globulin ratio (AGR), De Ritis ratio (DRR), and systemic immune-inflammation index (SII), was assessed in 613 patients treated with CN for mRCC. Patients were randomly divided into train...
Source
#1Keiichiro Mori (Jikei University School of Medicine)H-Index: 10
#2Satoshi Katayama (Medical University of Vienna)H-Index: 3
Last. Shahrokh F. Shariat (UTSW: University of Texas Southwestern Medical Center)H-Index: 136
view all 19 authors...
Introduction null This study aimed to evaluate the concordance in tumor stage and grade between ureteroscopic (URS) biopsy and radical nephroureterectomy (RNU) in patients with upper tract urothelial carcinoma (UTUC). null Patients and methods null Records of 1,214 UTUC patients who had undergone URS biopsy followed by RNU were included. Univariable and multivariable logistic regression analyses were performed to identify factors contributing to the pathological upstaging. null Results null The ...
Source
#1Ekaterina Laukhtina (Medical University of Vienna)H-Index: 8
#2Victor M. Schuettfort (UHH: University of Hamburg)H-Index: 5
Last. Shahrokh F. ShariatH-Index: 136
view all 23 authors...
Elevated preoperative plasma level of endoglin has been associated with worse oncologic outcomes in various malignancies. The present large-scale study aimed to determine the predictive and prognostic values of preoperative endoglin with regard to clinicopathologic and survival outcomes in patients treated with radical cystectomy (RC) for nonmetastatic urothelial carcinoma of the bladder (UCB). We prospectively collected preoperative blood samples from 1036 consecutive patients treated with RC f...
Source
#1Satoshi KatayamaH-Index: 3
Last. Abdulmajeed AydhH-Index: 5
view all 23 authors...
Source
#1Hadi Mostafaei (Tabriz University of Medical Sciences)H-Index: 9
#2Hanieh Salehi-Pourmehr (Tabriz University of Medical Sciences)H-Index: 8
Last. Victor M. Schuettfort (UHH: University of Hamburg)H-Index: 5
view all 18 authors...
Abstract null null Context null The choice of the most efficacious drug for patients with idiopathic overactive bladder (IOAB) remains challenging. null null null Objective null The aim of this network meta-analysis was to determine the most efficacious oral antimuscarinic or β-adrenoceptor agonist accounting for adverse events for the management of IOAB. null null null Evidence acquisition null A comprehensive electronic search was done in MEDLINE, EMBASE, Cochrane Central Register of Controlle...
Source
#1Hadi Mostafaei (Medical University of Vienna)H-Index: 9
#2Keiichiro Mori (Jikei University School of Medicine)H-Index: 10
Last. Shahrokh F. Shariat (MSMU: I.M. Sechenov First Moscow State Medical University)H-Index: 136
view all 11 authors...
CONTEXT The role of a nocebo response in managing urology patients is unclear. OBJECTIVE To assess the nocebo response in randomized placebo-controlled overactive bladder (OAB) trials of pharmacological treatment by investigating the adverse events in the placebo arms. EVIDENCE ACQUISITION PubMed, Scopus, Embase, and Cochrane Central Register of Controlled Trials were searched to identify potential randomized controlled trials published from 1998 to November 2019. After evaluating the risk of bi...
Source
#1Nico C. GrossmannH-Index: 5
Last. Satoshi KatayamaH-Index: 3
view all 16 authors...
Source
This website uses cookies.
We use cookies to improve your online experience. By continuing to use our website we assume you agree to the placement of these cookies.
To learn more, you can find in our Privacy Policy.